The Comparison of Wet Suction and Dry Suction Technique in EUS-FNA for the Outcomes in Pancreatic Solid Lesions
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03821974 |
|
Recruitment Status :
Completed
First Posted : January 30, 2019
Last Update Posted : June 16, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pancreatic Solid Lesions | Procedure: wet suction technique Procedure: dry suction technique | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 50 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Diagnostic |
| Official Title: | The Comparison of Wet Suction Technique and Dry Suction Technique in Endoscopic Ultrasound-guided Fine-needle Aspiration (EUS-FNA) for the Outcomes in Pancreatic Solid Lesions: a Prospective, Randomized Controlled, Blinded Trial |
| Actual Study Start Date : | January 3, 2019 |
| Actual Primary Completion Date : | September 30, 2019 |
| Actual Study Completion Date : | March 31, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: dry group
The sequence of the technique of the puncture is dry-wet-dry-wet.
|
Procedure: wet suction technique
For the wet suction technique, after removing the stylet, the needle was flushed with 2 mL of saline solution to replace the column of air with saline solution. A 10-mL suction syringe, loaded to 5ml negative pressure, was attached in a "locked" position to the needle after flushing the needle with saline solution. The needle is moved back and forth 20-30 times by applying negative pressure suction within the lesion. Afterwards, the needle is withdrawn from the lesion. Procedure: dry suction technique For the dry suction technique, after locating by EUS, the stylet was removed from the needle before performing FNA. A 10-mL syringe, loaded to 5ml negative pressure, was attached in a "locked" position to the needle. Suction was applied after the lesion was punctured. The needle is moved back and forth 20-30 times by applying negative pressure suction within the lesion. Afterwards, the needle is withdrawn from the lesion. |
|
Experimental: wet group
The sequence of the technique of the puncture is wet-dry-wet-dry.
|
Procedure: wet suction technique
For the wet suction technique, after removing the stylet, the needle was flushed with 2 mL of saline solution to replace the column of air with saline solution. A 10-mL suction syringe, loaded to 5ml negative pressure, was attached in a "locked" position to the needle after flushing the needle with saline solution. The needle is moved back and forth 20-30 times by applying negative pressure suction within the lesion. Afterwards, the needle is withdrawn from the lesion. Procedure: dry suction technique For the dry suction technique, after locating by EUS, the stylet was removed from the needle before performing FNA. A 10-mL syringe, loaded to 5ml negative pressure, was attached in a "locked" position to the needle. Suction was applied after the lesion was punctured. The needle is moved back and forth 20-30 times by applying negative pressure suction within the lesion. Afterwards, the needle is withdrawn from the lesion. |
- The primary outcome is defined as the overall diagnosis yield of solid lesions by EUS-FNA with each aspiration technique. [ Time Frame: 20 weeks ]The primary outcome is defined as the overall diagnosis yield of solid lesions by EUS-FNA with each aspiration technique.
- The second outcome is defined as the diagnose yield of first pass of solid lesions by EUS-FNA with each aspiration technique. [ Time Frame: 20 weeks ]The second outcome is defined as the diagnose yield of first pass of solid lesions by EUS-FNA with each aspiration technique.
- The third outcome is the diagnose yield in benign solid lesions by EUS-FNA with each aspiration technique. [ Time Frame: 20 weeks ]The third outcome is the diagnose yield in benign solid lesions by EUS-FNA with each aspiration technique.
- The forth outcome is the diagnose yield in malignant solid lesions by EUS-FNA with each aspiration technique. [ Time Frame: 20 weeks ]The forth outcome is the diagnose yield in malignant solid lesions by EUS-FNA with each aspiration technique.
- The fifth outcome is the diagnose yield in solid lesions in different parts of the pancreas by EUS-FNA with each aspiration technique. [ Time Frame: 20 weeks ]The fifth outcome is the diagnose yield in solid lesions in different parts of the pancreas by EUS-FNA with each aspiration technique.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age > 18 years, < 80 years
- female or male
- Patients are required to undergo EUS-FNA after undergoing imaging examination (MRI, CT, or ultrasonography) which identify that the pancreatic lesions are existing and solid.
- Agree to attend this study and signed informed consent letter
Exclusion Criteria:
- bad physical condition, including hemoglobin ≤ 8.0 g/dl, severe cardiorespiratory dysfunction, and so on
- Coagulopathy (platelet count < 50,000/mm3, international normalized ratio > 1.5) or having taken oral anticoagulation agents such as aspirin or warfarin in the previous week
- Be rejected by anesthesia
- Acute pancreatitis in the previous 2 weeks
- Pregnant or lactation period
- Psychiatric disease, drug addiction, or other reason for unreliable follow-up or questionnaires
- Don't agree to attend this study and absence of informed consent
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03821974
| China, Hunan | |
| The third Xiangya Hospital of central south University | |
| Changsha, Hunan, China, 410003 | |
| Principal Investigator: | Li Tian, MD | The Third Xiangya Hospital of Central South University | |
| Principal Investigator: | Ting Tong, MD | The Third Xiangya Hospital of Central South University |
| Responsible Party: | The Third Xiangya Hospital of Central South University |
| ClinicalTrials.gov Identifier: | NCT03821974 |
| Other Study ID Numbers: |
EUS2019-001 |
| First Posted: | January 30, 2019 Key Record Dates |
| Last Update Posted: | June 16, 2021 |
| Last Verified: | June 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Pancreatic solid lesions wet suction technique dry suction technique |

